Addex Therapeutics, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, reported its Q3 2023 financial results for the period ended September 30, 2023 and provides a corporate update.
Addex Therapeutics, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, reported its Q3 2023 financial results for the period ended September 30, 2023 and provides a corporate update.